Kondo K, Okuno T, Eguchi T, Yasui T, Nakamura R, Saruta T
Endocrinol Jpn. 1979 Dec;26(6):713-7. doi: 10.1507/endocrj1954.26.713.
The effects of intracerebroventricular administrations of three natural angiotensins, angiotensin I (ANG I 3.8 X 10-11-9.4 X10-10 mol/kg body weight), II (9.6 X 10-12-2.4 X 10-10 mol/kg body weight) and III (2.7 X 10-10 2.5 X 10-9 mol/kg body weight) on systemic blood pressure were investigated in conscious rats. Angiotensin II (ANG II), ANG I and angiotensin III (ANG III), increased blood pressure in a dose-related manner. The order of potency of angiotensins was ANG II greater than ANG I greater than ANG III. The intraventricular administration of a converting enzyme inhibitor (SQ 14225, 6.9 X10-8 mol/kg) abolished the central effect of ANG I, while an angiotensin II analogue ([Sar1-Ala8]ANG II, 1.1 X 10-8 mol/kg) administered intraventricularly inhibited the central pressor effects of these three angiotensins. These results suggest that ANG II is a main mediator of the renin-angiotensin system in the central nervous system.
在清醒大鼠中研究了脑室内注射三种天然血管紧张素,即血管紧张素I(3.8×10⁻¹¹ - 9.4×10⁻¹⁰摩尔/千克体重)、血管紧张素II(9.6×10⁻¹² - 2.4×10⁻¹⁰摩尔/千克体重)和血管紧张素III(2.7×10⁻¹⁰ - 2.5×10⁻⁹摩尔/千克体重)对全身血压的影响。血管紧张素II(ANG II)、血管紧张素I和血管紧张素III(ANG III)均以剂量相关的方式升高血压。血管紧张素的效力顺序为ANG II>ANG I>ANG III。脑室内注射一种转化酶抑制剂(SQ 14225,6.9×10⁻⁸摩尔/千克)消除了ANG I的中枢作用,而脑室内注射一种血管紧张素II类似物([Sar¹ - Ala⁸]ANG II,1.1×10⁻⁸摩尔/千克)抑制了这三种血管紧张素的中枢升压作用。这些结果表明,ANG II是中枢神经系统中肾素 - 血管紧张素系统的主要介质。